Indaptus Therapeutics Inc
NASDAQ:INDP
Indaptus Therapeutics Inc
NASDAQ:INDP
Price:
2.31 USD
-3.75%
Market Closed
Updated:
May 18, 2024
Indaptus Therapeutics Inc
EPS (Diluted)
|
Indaptus Therapeutics Inc
EPS (Diluted) Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
EPS (Diluted)
-$1
|
CAGR 3-Years
32%
|
CAGR 5-Years
56%
|
CAGR 10-Years
32%
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$3
|
CAGR 3-Years
6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$15
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Indaptus Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-1.8
USD
-1.8
USD
Based on the financial report for Mar 31, 2024, Indaptus Therapeutics Inc's EPS (Diluted) amounts to -1.8 USD.
What is Indaptus Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
32%
32%
Over the last year, the EPS (Diluted) growth was 2%. The average annual EPS (Diluted) growth rates for Indaptus Therapeutics Inc have been 32% over the past three years , 56% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
